Validation of Rivaroxaban Assay for US Registration

Trial Profile

Validation of Rivaroxaban Assay for US Registration

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Therapeutic Use
  • Sponsors Stago
  • Most Recent Events

    • 13 Feb 2017 Status changed from recruiting to completed.
    • 08 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
    • 08 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top